Home > Boards > US Listed > Medical - Drugs > Merck & Co. Inc. (MRK)

MRK’s women’s-health/branded-generics/biosimilars spin-off will be called…Organon!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 748
Posts 115,204
Boards Moderated 14
Alias Born 09/05/02
160x600 placeholder
Merck Begins Tender Offer to Acquire Pandion Therapeutics Business Wire - 3/4/2021 6:45:00 AM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 6th Update Dow Jones News - 3/3/2021 7:47:00 AM
Merck to Present at the Barclays Global Healthcare Conference Business Wire - 3/3/2021 6:45:00 AM
Merck to Present New Data from Various HIV Research and Development Programs at CROI 2021 Business Wire - 3/3/2021 6:45:00 AM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 6th Update Dow Jones News - 3/2/2021 10:14:00 PM
Biden Expects U.S. to Have Enough Vaccines for All Adults by End of May -- 5th Update Dow Jones News - 3/2/2021 6:56:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--3rd Update Dow Jones News - 3/2/2021 5:55:00 PM
Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufac... Business Wire - 3/2/2021 4:30:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--3rd Update Dow Jones News - 3/2/2021 2:22:00 PM
Merck to Help Johnson & Johnson Make Its Covid-19 Vaccine--2nd Update Dow Jones News - 3/2/2021 12:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:58:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:56:48 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:50:45 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:48:40 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:44:30 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:42:02 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:36:35 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 11:14:45 AM
Merck to Help J&J Make Its Covid-19 Vaccine, Biden to Announce--Update Dow Jones News - 3/2/2021 9:54:00 AM
Biden to Announce Merck Will Help Make Johnson & Johnson Vaccine Dow Jones News - 3/2/2021 9:21:00 AM
Merck Announces Fifth Round of Global Grants to Tackle Maternal Mortality and Promote Health Equity Worldwide Business Wire - 3/2/2021 8:00:00 AM
Merck Withdraws U.S. Indication for KEYTRUDA Dow Jones News - 3/1/2021 5:05:00 PM
Merck gives update on U.S. KEYTRUDA indication in metastatic small cell lung cancer Seeking Alpha - 3/1/2021 4:10:02 PM
Merck Provides Update on KEYTRUDA® (pembrolizumab) Indication in Metastatic Small Cell Lung Cancer in the US Business Wire - 3/1/2021 4:05:00 PM
Merck: FDA to Review Gefapixant for Refractory, Unexplained Chronic Cough Dow Jones News - 3/1/2021 7:48:00 AM
DewDiligence Member Level  Tuesday, 04/28/20 10:05:16 PM
Re: DewDiligence post# 508
Post # of 586 
MRK’s women’s-health/branded-generics/biosimilars spin-off will be called…Organon!

The original Organon was a subsidiary of Akzo Nobel that Schering-Plough acquired thirteen years ago (#msg-17791687).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences